Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Thromboresistance and Functional Healing in the COBRA PzF Stent versus Competitor DES: Implications for Dual Anti-Platelet Therapy.

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie FD, Virmani R, Finn AV.

EuroIntervention. 2018 Oct 30. pii: EIJ-D-18-00740. doi: 10.4244/EIJ-D-18-00740. [Epub ahead of print]

2.

Nonatherosclerotic Vascular Disease in Women.

Jinnouchi H, Finn AV, Virmani R.

Tex Heart Inst J. 2018 Aug 1;45(4):233-235. doi: 10.14503/THIJ-18-6675. eCollection 2018 Aug. No abstract available.

3.

Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension.

Torii S, Mori H, Jinnouchi H, Sakamoto A, Finn A, Virmani R.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3060-S3063. doi: 10.21037/jtd.2018.08.134. No abstract available.

4.

Micro-Computed Tomography Demonstration of Multiple Plaque Ruptures in a Single Individual Presenting With Sudden Cardiac Death.

Jinnouchi H, Torii S, Kutyna M, Sakamoto A, Kolodgie FD, Finn AV, Virmani R.

Circ Cardiovasc Imaging. 2018 Oct;11(10):e008331. doi: 10.1161/CIRCIMAGING.118.008331. No abstract available.

PMID:
30354478
5.

Coronary artery calcification: recent developments in our understanding of its pathologic and clinical significance.

Sakamoto A, Virmani R, Finn AV.

Curr Opin Cardiol. 2018 Nov;33(6):645-652. doi: 10.1097/HCO.0000000000000558.

PMID:
30307412
6.

Is there an effect of antithrombotics on carotid intraplaque haemorrhage?

Guo L, Virmani R, Finn AV.

Eur Heart J. 2018 Sep 21;39(36):3377-3380. doi: 10.1093/eurheartj/ehy583. No abstract available.

PMID:
30212877
7.

Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View.

Sakamoto A, Jinnouchi H, Torii S, Virmani R, Finn AV.

Bioengineering (Basel). 2018 Sep 4;5(3). pii: E71. doi: 10.3390/bioengineering5030071. Review.

8.

Long-Term Vasomotion After Absorb: Fact or Fiction?

Jinnouchi H, Virmani R, Finn AV.

JACC Cardiovasc Interv. 2018 Aug 27;11(16):1572-1575. doi: 10.1016/j.jcin.2018.05.028. Epub 2018 May 24. No abstract available.

PMID:
30139464
9.

Histopathologic and physiologic effect of overlapping vs single coronary stents: impact of stent evolution.

Sakamoto A, Torii S, Jinnouchi H, Virmani R, Finn AV.

Expert Rev Med Devices. 2018 Sep;15(9):665-682. doi: 10.1080/17434440.2018.1515012. Epub 2018 Sep 7.

PMID:
30132713
10.

An uncommon but important cause of stent thrombosis: Kounis syndrome.

Torii S, Virmani R, Finn A.

Cardiovasc Revasc Med. 2018 Aug 14. pii: S1553-8389(18)30357-9. doi: 10.1016/j.carrev.2018.08.005. [Epub ahead of print] No abstract available.

PMID:
30121221
11.

Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents-Brief Report.

Harari E, Guo L, Smith SL, Paek KH, Fernandez R, Sakamoto A, Mori H, Kutyna MD, Habib A, Torii S, Cornelissen A, Jinnouchi H, Gupta A, Kolodgie FD, Virmani R, Finn AV.

Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2217-2224. doi: 10.1161/ATVBAHA.118.311321.

PMID:
30026269
12.

Pathologic intimal thickening: Are we any closer to understand early transitional plaques that lead to symptomatic disease?

Sakamoto A, Torii S, Jinnouchi H, Finn AV, Virmani R, Kolodgie FD.

Atherosclerosis. 2018 Jul;274:227-229. doi: 10.1016/j.atherosclerosis.2018.04.033. Epub 2018 May 4. No abstract available.

PMID:
29801687
13.

Myocardial Bridge and the Progression of Atherosclerotic Plaque in the Proximal Segment.

Torii S, Virmani R, Finn A.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1250-1251. doi: 10.1161/ATVBAHA.118.311065. No abstract available.

PMID:
29793989
14.

Pathological mechanisms of left main stent failure.

Mori H, Torii S, Harari E, Jinnouchi H, Brauman R, Smith S, Kutys R, Fowler D, Romero M, Virmani R, Finn AV.

Int J Cardiol. 2018 Jul 15;263:9-16. doi: 10.1016/j.ijcard.2018.02.119.

PMID:
29754928
15.

Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.

Torii S, Yahagi K, Mori H, Harari E, Romero ME, Kolodgie FD, Young B, Ragheb A, Virmani R, Finn AV.

J Vasc Interv Radiol. 2018 Jul;29(7):1041-1049.e3. doi: 10.1016/j.jvir.2018.02.006. Epub 2018 May 10.

PMID:
29754850
16.

Comparison of Acute Thrombogenicity for Magnesium versus Stainless Steel Stents in a Porcine Arteriovenous Shunt Model.

Lipinski MJ, Acampado E, Cheng Q, Adams L, Torii S, Gai J, Torguson R, Hellinga DG, Joner M, Harder C, Zumstein P, Finn AV, Kolodgie FD, Virmani R, Waksman R.

EuroIntervention. 2018 May 8. pii: EIJ-D-17-00958. doi: 10.4244/EIJ-D-17-00958. [Epub ahead of print]

17.

Acute Thrombogenicity of Fluoropolymer-Coated Versus Biodegradable and Polymer Free Stents.

Torii S, Cheng Q, Mori H, Lipinski MJ, Acampado E, Perkins LEL, Hossainy SF, Pacetti SD, Kolodgie FD, Virmani R, Finn AV.

EuroIntervention. 2018 Apr 3. pii: EIJ-D-17-00728. doi: 10.4244/EIJ-D-17-00728. [Epub ahead of print]

18.

A new category stent with novel polyphosphazene surface modification.

Mori H, Jinnouchi H, Diljon C, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV.

Future Cardiol. 2018 May 1;14(3):225-235. doi: 10.2217/fca-2017-0103. Epub 2018 Mar 27.

19.

Are characteristics of plaque erosion defined by optical coherence tomography similar to true erosion in pathology?

Jinnouchi H, Virmani R, Finn AV.

Eur Heart J. 2018 Jun 7;39(22):2086-2089. doi: 10.1093/eurheartj/ehy113. No abstract available.

PMID:
29547936
20.

The Authors Reply.

Mori H, Virmani R, Finn AV.

JACC Cardiovasc Imaging. 2018 Mar;11(3):518. doi: 10.1016/j.jcmg.2018.01.010. No abstract available.

PMID:
29519343

Supplemental Content

Loading ...
Support Center